Med Paper (CAS:MDP) Debt-to-EBITDA : 0.00 (As of . 20)


CAS:MDP Med Paper CAS:MDP
9 GF Score
Price MAD24.71
! 1 Warning Sign
View Full Analysis

What is Med Paper Debt-to-EBITDA?

Med Paper CAS:MDP -1.16% 9 Debt-to-EBITDA is 0.00 as of . 20. GuruFocus rates CAS:MDP with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 208 Forest Products companies, Med Paper ranks worse than 480768.75% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Med Paper's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was MAD0.00 Mil. Med Paper's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was MAD0.00 Mil. Med Paper's annualized EBITDA for the quarter that ended in . 20 was MAD0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Med Paper's Debt-to-EBITDA or its related term are showing as below:

CAS:MDP's Debt-to-EBITDA is not ranked *
in the Forest Products industry.
Industry Median: 3.285
* Ranked among companies with meaningful Debt-to-EBITDA only.

Med Paper  (CAS:MDP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Med Paper Debt-to-EBITDA Related Terms

Med Paper Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Med Paper's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Paper Debt-to-EBITDA Chart

Med Paper Annual Data
Trend
Debt-to-EBITDA

Med Paper Semi-Annual Data
Debt-to-EBITDA

CAS:MDP vs SLVM: Debt-to-EBITDA Comparison

For the Paper & Paper Products subindustry, Med Paper's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Med Paper Debt-to-EBITDA vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, Med Paper's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Med Paper's Debt-to-EBITDA falls into.


CAS:MDP
9GF Score
Med Paper CAS:MDP
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Paper Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Med Paper's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=( + ) / N/A
=N/A

Med Paper's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=( + ) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 0.00 mean?
Med Paper (CAS:MDP) has a Debt-to-EBITDA of 0.00 as of . 20. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Med Paper. According to the industry distribution chart, Med Paper ranks #999999 out of 208 companies in the Forest Products industry.
Is Med Paper's Debt-to-EBITDA too high?
Med Paper's current Debt-to-EBITDA is 0.00. Based on the distribution chart, Med Paper ranks #999999 out of 208 companies in the Forest Products industry, which is in the bottom quartile relative to peers. Overall, Med Paper has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Med Paper's Debt-to-EBITDA compare to SLVM?
According to the Forest Products industry distribution chart, Med Paper ranks #999999 out of 208 companies for Debt-to-EBITDA. This places Med Paper in the lower half of its industry. The industry median Debt-to-EBITDA is 3.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Forest Products company?
The median Debt-to-EBITDA among Forest Products companies is 3.29, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Med Paper. For the Forest Products industry, the median Debt-to-EBITDA is 3.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Paper's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Paper stock overvalued right now?
Med Paper (CAS:MDP) has a current Debt-to-EBITDA of 0.00. The current Debt-to-EBITDA is 0.00. Med Paper's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Med Paper (CAS:MDP), the current Debt-to-EBITDA is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med Paper Business Description

Address Route de Tetouan Lot 19, BP n 400, Mghogha Industrial Zone, Tangier, MAR, 20400
Med Paper is a specialist paper manufacturer in Morocco.
9GF Score

Get the complete analysis for CAS:MDP

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD24.71
Price